Ligand Pharmaceuticals (LGND) short interest

Shares sold short
2.5M

2.5M Ligand Pharmaceuticals shares were sold short and not yet covered at the October 30, 2026 settlement date, down 1.5% from the previous report. That is 12.3% of shares outstanding and 10.53 days of average volume. Source: FINRA.

Key facts

Shares sold short
2.5Msettlement date Oct 30, 2026
Change from previous report
−37,822 (−1.5%)
Short interest, % of shares outstanding
12.3%not of float
Days to cover
10.53short interest ÷ FINRA's average daily volume
Average daily volume
234,088shares, as FINRA computes it
Short interest on May 15, 2026
1.5Moldest report held
Short sale volume, share of off-exchange volume
70.3%last 30 trading days; not short interest
Fails to deliver, latest
43shares on Oct 2, 2026 (SEC)

Source: FINRA, short interest for the settlement date , published about seven business days later — not today's figure. FINRA is the owner and source of this data. Shares outstanding are the company's market value divided by its share price, both from Yahoo Finance quotes; that counts every share, not just the float, so a percent of float would be higher, and for a company with more than one class of shares it counts all classes. Figures, not advice.

FINRA · 12 settlement dates

Short interest by settlement date

Ligand Pharmaceuticals short interest, report by report

Ligand Pharmaceuticals (LGND) short interest by FINRA settlement date
Settlement dateShares sold shortChangeAverage daily volumeDays to coverNote
2,464,093 1.5% down234,08810.53
2,501,915 6.6% down237,67710.53
2,677,998 1.7% up306,6508.73
2,632,434 6.1% up194,50913.53
2,480,981 1.3% up175,76414.12
2,448,076 12.8% up279,4238.76
2,169,585 13.1% up294,5877.36
1,918,207 9.6% down384,5864.99
2,121,617 25.6% up814,8372.60
1,689,714 3.1% up202,9058.33
1,638,411 8.9% up200,3708.18
1,505,179 3.4% up225,6826.67

Source: FINRA, settlement dates May 15, 2026 to October 30, 2026. Change is on the previous report as FINRA restates it. Days to cover is short interest divided by FINRA's average daily volume, worked out here (FINRA's own printed figure is floored at 1 and capped at 999.99); with no average volume reported it is a dash. A dash means there is no figure; nothing is filled in.

Daily short sale volume — not short interest

This is a different figure. Short sale volume counts the shares sold short in each day's off-exchange trades reported to FINRA (trades on stock exchanges are not in it), and much of it is market makers selling short to fill buy orders, then covering within the day. It says nothing about how many shares are held short; that is the short interest above.

Over the 30 trading days to November 13, 2026, 70.3% of LGND's off-exchange reported volume was short sale volume. That is a share of off-exchange trading in regular hours only, not of all trading in the stock.

Ligand Pharmaceuticals (LGND) daily short sale volume in off-exchange reported trades
Trade dateShort sale volumeOff-exchange reported volumeShare of off-exchange volume
34,12045,11975.6%
70,927101,29670.0%
34,06945,58074.7%
41,40267,86161.0%
41,31657,20172.2%
31,28847,29566.2%
72,916104,06170.1%
34,40057,82359.5%
39,07956,17969.6%
67,978110,51961.5%
115,424151,46976.2%
104,371162,12164.4%
106,742140,87575.8%
28,96353,96253.7%
64,35985,35075.4%
169,519187,30090.5%
98,959166,54459.4%
50,64985,28859.4%
42,75458,12273.6%
27,73751,01754.4%
45,54363,28972.0%
91,337153,38459.5%
58,05595,78560.6%
48,56687,34255.6%
47,36168,62669.0%
62,76274,38884.4%
124,771155,05080.5%
114,106129,00688.5%
41,49965,93362.9%
49,76459,82783.2%

Source: FINRA daily short sale volume (all off-exchange trade reporting facilities), trade dates October 5, 2026 to November 13, 2026; volumes rounded to whole shares. Short sale volume already includes trades marked short exempt; total volume is off-exchange reported volume in regular trading hours. A day without a row had no off-exchange reported trades in LGND.

Fails to deliver from the SEC

A fail to deliver is a sale whose shares were not delivered to the buyer by settlement. The figure for each day is the total still outstanding in the clearing system that day — a balance, not that day's new fails — and it covers every seller, not only short sellers.

Ligand Pharmaceuticals (LGND) fails to deliver by settlement date
Settlement dateShares failed to deliverPrevious closeValue
43$302.74$13,018
156$310.36$48,416
546$298.41$162,932
94$283.49$26,648
219$284.70$62,349
54$276.98$14,957
2,018$289.25$583,707
5,586$286.92$1,602,735
211$284.27$59,981
10$284.10$2,841
1,681$280.49$471,504
182$284.52$51,783
6$290.71$1,744

Source: SEC fails-to-deliver data, August 16–31, 2026; September 1–15, 2026; September 16–30, 2026; October 1–15, 2026; published about two weeks after each half-month. Days not listed had no fails outstanding. Value is shares times the previous close.

More on LGND

Short interest across the market

LGND: 12.3% of shares outstanding, down 37,822 shares from the previous report.

Ligand Pharmaceuticals short interest: questions and answers

What is Ligand Pharmaceuticals's short interest?

FINRA reported 2.5M LGND shares sold short and not yet covered at the October 30, 2026 settlement date, 12.3% of the 20M shares outstanding (market value divided by share price; a percent of float would be higher). FINRA publishes each report about seven business days after its settlement date.

Did short interest in LGND rise or fall?

It fell by 37,822 shares (1.5%) from the previous report, to 2.5M shares. Over the 12 reports held, back to May 15, 2026, it went from 1.5M to 2.5M shares.

What does days to cover mean for Ligand Pharmaceuticals?

It is the shares sold short divided by average daily trading volume: 2.5M over 234,088 shares a day gave 10.53 days at the October 30, 2026 settlement date. It says how many days of normal trading it would take short sellers to buy back their shares at that pace.

How is short sale volume different from short interest?

Short interest counts open short positions on a settlement date. Short sale volume counts shares sold short in one day's off-exchange reported trades, much of it by market makers who close the same day, so it is not a count of open positions. Over the last 30 trading days, 70.3% of LGND's off-exchange reported volume (regular trading hours) was short sale volume; exchange trades are not in that total.

Does Ligand Pharmaceuticals have fails to deliver?

The SEC's data shows fails on 13 settlement days from August 20, 2026 to October 2, 2026, the largest 5,586 shares on September 3, 2026. A fail is a sale whose shares were not delivered on time; the figure is the balance outstanding that day.

Cite this page

Funkfolio, “Ligand Pharmaceuticals (LGND) short interest: 2.5M shares”, data as of 30 October 2026. https://funkfolio.com/stock/LGND/short-interest

Underlying data: FINRA short interest and daily short sale volume; SEC fails-to-deliver data; shares outstanding from Yahoo Finance quotes.